NYSE:CC - Chemours Stock Price, Forecast & News

Chemours' stock was trading at $10.66 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CC stock has decreased by 12.5% and is now trading at $9.33. View which stocks have been mosted impacted by Coronavirus.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 8 hold ratings, 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Chemours.

Chemours is scheduled to release its next quarterly earnings announcement on Thursday, May 7th 2020. View our earnings forecast for Chemours.

Chemours Co (NYSE:CC) released its quarterly earnings data on Thursday, February, 13th. The specialty chemicals company reported $0.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.14. The specialty chemicals company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.37 billion. Chemours had a positive return on equity of 52.65% and a negative net margin of 0.92%. View Chemours' earnings history.

Chemours announced a quarterly dividend on Wednesday, February 12th. Stockholders of record on Thursday, February 27th will be given a dividend of $0.25 per share on Monday, March 16th. This represents a $1.00 annualized dividend and a yield of 10.72%. The ex-dividend date of this dividend is Wednesday, February 26th. View Chemours' dividend history.

Chemours issued an update on its FY20 earnings guidance on Thursday, February, 13th. The company provided EPS guidance of $2.60-$3.55 for the period, compared to the Thomson Reuters consensus estimate of $3.22.

12 brokers have issued 1-year price targets for Chemours' stock. Their forecasts range from $10.00 to $42.00. On average, they anticipate Chemours' stock price to reach $19.95 in the next year. This suggests a possible upside of 113.8% from the stock's current price. View analysts' price targets for Chemours.

Media coverage about CC stock has trended very positive on Tuesday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Chemours earned a news sentiment score of 3.2 on InfoTrie's scale. They also assigned headlines about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutChemours.

Chemours saw a increase in short interest in the month of March. As of March 13th, there was short interest totaling 16,479,800 shares, an increase of 10.5% from the February 27th total of 14,910,000 shares. Based on an average daily volume of 3,190,000 shares, the short-interest ratio is presently 5.2 days. Approximately 10.2% of the shares of the company are sold short. View Chemours' Current Options Chain.

Some companies that are related to Chemours include Johnson Matthey (JMPLY), KURARAY CO LTD/ADR (KURRY), Huntsman (HUN), Balchem (BCPC), Ashland Global (ASH), W. R. Grace & Co (GRA), Olin (OLN), Univar (UNVR), Innospec (IOSP), PQ Group (PQG), Ingevity (NGVT), GCP Applied Technologies (GCP), Livent (LTHM), Innophos (IPHS) and Hawkins (HWKN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include E I Du Pont De Nemours And Co (DD), Micron Technology (MU), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Energy Transfer LP Unit (ET), Alibaba Group (BABA), Pfizer (PFE), Intel (INTC) and Johnson & Johnson (JNJ).

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CC stock can currently be purchased for approximately $9.33.

Chemours has a market capitalization of $1.53 billion and generates $5.53 billion in revenue each year. The specialty chemicals company earns $-52,000,000.00 in net income (profit) each year or $2.51 on an earnings per share basis. Chemours employs 7,000 workers across the globe. View additional information about Chemours.

The official website for Chemours is http://www.chemours.com/.

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]